<DOC>
	<DOCNO>NCT02542098</DOCNO>
	<brief_summary>The purpose study evaluate safety , pharmacokinetics ( PK ) , effectiveness Hydrocodone Bitartrate ( HYD ) tablets child moderate severe pain require around-the-clock opioid analgesic .</brief_summary>
	<brief_title>Safety , Pharmacokinetics ( PK ) , Effectiveness Hydrocodone Bitartrate ( HYD ) Extended-Release Tablets Children</brief_title>
	<detailed_description />
	<mesh_term>Hydrocodone</mesh_term>
	<criteria>Inclusion Criteria include : 1 . Males female , age 12 17 year , pain severe enough require daily , aroundtheclock opioid treatment dose equivalent least 20 mg daily hydrocodone least 2 week . 2 . Patients must stable vital sign hemoglobin oxygen saturation , eg , measure pulse oximetry ( SpO2 ) . 3 . Patients must willing able swallow medicinal tablet . 4 . Female patient childbearing potential must negative pregnancy test within 24 hour prior start study drug treatment . 5 . Female patient sexually active must use ( continue use throughout study ) acceptable method birth control , per investigator 's discretion . 6 . Patients patient 's parent/caregiver must compliant protocol , ie , must able perform study assessment understand complete ageappropriate scale rate pain intensity . 7 . Patients must cognitive developmental delay condition would preclude complete ageappropriate pain scale . Exclusion Criteria include : 1 . Patients require start total daily dose HYD &gt; 120 mg. 2 . Patients surgery within 72 hour prior start study drug treatment . 3 . Patients plan surgery study exclude . 4 . Female patient pregnant lactate . 5 . Patients allergic hydrocodone component HYD history allergy opioids . 6 . Patients receive expect receive investigational drug/therapy study drug treatment followup period . 7 . Patients anticipated receive hydrocodone hydromorphonecontaining product ( study drug ) study 3 day prior initiation treatment study drug . 8 . Patients history alcohol , medication , illicit drug abuse addiction and/or opioid abuse addiction time . 9 . Patients contraindication blood sampling . Other protocolspecific inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>